NDC 0088-2500-34
Apidra 100 [iU]/mL
insulin glulisine · INJECTION, SOLUTION
Apidra is a injection, solution containing insulin glulisine at a strength of 100 [iU]/mL. Manufactured by sanofi-aventis U.S. LLC.
Key Facts
- Brand Name
- Apidra
- Generic Name
- insulin glulisine
- NDC Code (Package)
0088-2500-34- NDC Code (Product)
0088-2500- Manufacturer
- sanofi-aventis U.S. LLC
- Strength
- 100 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA021629
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 02/24/2009
Recall History
No Recall HistoryView Full Drug Page
Apidra — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.